Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

671 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia.
Gigante M, Santangelo L, Diella S, Caridi G, Argentiero L, D''Alessandro MM, Martino M, Stea ED, Ardissino G, Carbone V, Pepe S, Scrutinio D, Maringhini S, Ghiggeri GM, Grandaliano G, Giordano M, Gesualdo L. Gigante M, et al. Among authors: gesualdo l. Nephron. 2016;133(3):193-204. doi: 10.1159/000446663. Epub 2016 Jul 9. Nephron. 2016. PMID: 27394135
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R, Aghemo A, Chirianni A, Fabrizi F, Gesualdo L, Giannini EG, Maggi P, Montinaro V, Paoletti E, Persico M, Perticone F, Petta S, Puoti M, Raimondo G, Rendina M, Zignego AL; Italian Society of Nephrology (SIN); Italian Association for the Study of the Liver (AISF); Italian Society of Infectious and Tropical Disease (SIMIT); Italian Society of Internal Medicine (SIMI). Minutolo R, et al. Among authors: gesualdo l. Infection. 2019 Feb;47(1):141-168. doi: 10.1007/s15010-018-1209-2. Epub 2018 Sep 25. Infection. 2019. PMID: 30255389
DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via complement-mediated cellular senescence.
Pesce F, Stea ED, Divella C, Accetturo M, Laghetti P, Gallo P, Rossini M, Cianciotta F, Crispino L, Granata A, Battaglia M, Lucarelli G, de Cordoba SR, Stallone G, Gesualdo L, Castellano G. Pesce F, et al. Among authors: gesualdo l. Am J Transplant. 2021 Feb;21(2):838-845. doi: 10.1111/ajt.16350. Epub 2020 Nov 1. Am J Transplant. 2021. PMID: 33091234 Free article.
Glomerulonephritis in AKI: From Pathogenesis to Therapeutic Intervention.
Pesce F, Stea ED, Rossini M, Fiorentino M, Piancone F, Infante B, Stallone G, Castellano G, Gesualdo L. Pesce F, et al. Among authors: gesualdo l. Front Med (Lausanne). 2021 Mar 2;7:582272. doi: 10.3389/fmed.2020.582272. eCollection 2020. Front Med (Lausanne). 2021. PMID: 33738291 Free PMC article. Review.
Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.
Stea ED, Skerka C, Accetturo M, Pesce F, Wiech T, Hartman A, Pontrelli P, Conserva F, Castellano G, Zipfel PF, Gesualdo L. Stea ED, et al. Among authors: gesualdo l. Front Immunol. 2022 Nov 14;13:1008294. doi: 10.3389/fimmu.2022.1008294. eCollection 2022. Front Immunol. 2022. PMID: 36451836 Free PMC article.
Impact of a Pro-Active Infectious Disease Consultation on the Management of a Multidrug-Resistant Organisms Outbreak in a COVID-19 Hospital: A Three-Months Quasi-Experimental Study.
Bavaro DF, De Gennaro N, Belati A, Diella L, Papagni R, Frallonardo L, Camporeale M, Guido G, Pellegrino C, Marrone M, Dell'Erba A, Gesualdo L, Brienza N, Grasso S, Columbo G, Moschetta A, Carpagnano GE, Daleno A, Minicucci AM, Migliore G, Saracino A. Bavaro DF, et al. Among authors: gesualdo l. Antibiotics (Basel). 2023 Apr 6;12(4):712. doi: 10.3390/antibiotics12040712. Antibiotics (Basel). 2023. PMID: 37107073 Free PMC article.
Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study.
Bavaro DF, Diella L, Belati A, Metrangolo G, De Santis L, Spada V, Camporeale M, Dargenio A, Brindicci G, Balena F, Fiordelisi D, Signorile F, Loseto G, Pasciolla C, Minoia C, Attolico I, Perrone T, Simone S, Rendina M, Giovine N, Di Gennaro F, Musto P, Guarini A, Di Leo A, Gesualdo L, Dell'Aera M, Saracino A. Bavaro DF, et al. Among authors: gesualdo l. Viruses. 2023 May 19;15(5):1199. doi: 10.3390/v15051199. Viruses. 2023. PMID: 37243285 Free PMC article.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Among authors: gesualdo l. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
671 results